亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Organ and tumor dosimetry of [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC

医学 剂量学 前列腺癌 吸收剂量 核医学 放射性配体 放射性核素治疗 累积剂量 放射治疗 肾 癌症 药代动力学 内科学 毒性 前列腺 泌尿科 肿瘤科 放射科 腮腺 正电子发射断层摄影术 队列
作者
Andrea Schaefer-Schuler,Arne Blickle,Sebastian Ganz,Sven Petto,Caroline Burgard,Tilman Speicher,Moritz B. Bastian,Stephan Maus,Mark Daniel Bartholomä,Samer Ezziddin,Florian Rosar
出处
期刊:European Journal of Nuclear Medicine and Molecular Imaging [Springer Science+Business Media]
卷期号:53 (13): 8519-8530
标识
DOI:10.1007/s00259-026-08171-z
摘要

Abstract Purpose Terbium-161 ( 161 Tb) has emerged as a promising radionuclide for radioligand therapy (RLT) due to its emission of Auger and conversion electrons, which may support therapeutic efficacy through increased local energy deposition. Despite growing research efforts aimed at the clinical potential of 161 Tb, dosimetric data, particularly for tumor lesions, remain scarce. To address this gap, we assessed tumor and organ dosimetry in mCRPC patients treated with [ 161 Tb]Tb-PSMA-617. Methods The study involved n = 15 patients with metastasized castration-resistant prostate cancer (mCRPC) participating in a registry (NCT04833517) and receiving [ 161 Tb]Tb-PSMA-617. All patients received a median of 2 (range: 1–3) cycles with mean administered activity of 6.0 ± 1.3 GBq and mean cumulative activity of 12.3 ± 4.6 GBq [ 161 Tb]Tb-PSMA-617. Hybrid dosimetry of organs at risk, including the salivary glands, the kidneys, the liver, and tumor lesions was performed analyzing whole-body planar and SPECT/CT images. Absorbed doses were estimated using OLINDA/EXM for 161 Tb. Tumor-to-organ ratios (TR) of mean tumor-absorbed doses over relevant organs at risk were calculated. Results Mean absorbed dose to kidneys, parotid glands, submandibular glands and liver was 0.70 ± 0.41 Gy/GBq, 0.40 ± 0.20 Gy/GBq, 0.36 ± 0.14 Gy/GBq and 0.13 ± 0.08 Gy/GBq, respectively. Tumor kinetics in 43 lesions demonstrated stable activity over time (mean half-life of all lesions: 44.07 h ± 15.88 h) delivering a mean overall absorbed tumor dose of 5.95 ± 3.60 Gy/GBq, the resulting TR over kidney and parotid gland were 10.55 ± 8.32 and 16.15 ± 11.85, respectively. Conclusion [ 161 Tb]Tb-PSMA-617 delivers high tumor-absorbed doses with tolerable doses to relevant organs at risk, translating into favorable tumor-to-normal-organ ratios. Dosimetry results confirm 161 Tb as a promising radionuclide for PSMA-targeted radioligand therapy in mCRPC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
彭于晏的应助被椰子云采纳,获得10
3秒前
4秒前
4秒前
小蘑菇的应助被海藻采纳,获得10
5秒前
找找完成签到 ,获得积分10
8秒前
南宫雪发布了新的文献求助30
8秒前
12秒前
12秒前
12秒前
ding的应助被coco采纳,获得10
12秒前
Maestro_S的应助被纯情的阁采纳,获得10
15秒前
海藻发布了新的文献求助10
16秒前
omoily发布了新的文献求助10
16秒前
Coral369发布了新的文献求助10
18秒前
自信紫夏完成签到,获得积分10
19秒前
ze完成签到,获得积分10
25秒前
VT发布了新的文献求助10
30秒前
31秒前
33秒前
情怀的应助被肉包子采纳,获得10
36秒前
36秒前
852的应助被Hidos采纳,获得30
37秒前
37秒前
王老裂发布了新的文献求助10
38秒前
38秒前
39秒前
h11的应助被纯情的阁采纳,获得10
39秒前
ze发布了新的文献求助10
40秒前
40秒前
王老裂发布了新的文献求助10
41秒前
王老裂发布了新的文献求助10
41秒前
余铸海完成签到,获得积分10
42秒前
王老裂发布了新的文献求助10
42秒前
42秒前
清爽笙完成签到,获得积分10
43秒前
h11的应助被ming采纳,获得10
45秒前
EllenLawliet发布了新的文献求助10
48秒前
论文真难写的应助被LX有理想采纳,获得10
50秒前
爆米花的应助被EllenLawliet采纳,获得10
52秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158601
求助须知:如何正确求助?哪些是违规求助? 9554379
关于积分的说明 21719104
捐赠科研通 7748129
什么是DOI,文献DOI怎么找? 3427052
关于科研通互助平台的介绍 2551912
邀请新用户注册赠送积分活动 2471285